Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Danny Dvir

Interventional Cardiology Seattle, WA Medical Doctor

NPI 1225311756 CMS profile 2777486

1959 Ne Pacific St, Seattle, WA 98195

Open in the dashboard

General payments

$373,805

189 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$5,700

1 holding reported · through program year 2025

Through program year 2025, Danny Dvir of Seattle, WA is reported in the CMS Open Payments database as having received $373,805 across 189 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $5,700 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $103 1
2021 General $109 1
2020 General $154,871 35
2019 General $218,723 152
2025 Ownership $5,700 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Danny Dvir
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Danny Dvir were reported at $103. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Danny Dvir Interventional Cardiology median Middle half National median
2019 $218,723 $1,097 $329–$3,048 $163
2020 $154,871 $473 $161–$1,480 $114
2021 $109 $677 $233–$1,827 $132
2022 $0 $978 $333–$2,724 $149
2023 $0 $1,136 $382–$2,986 $160
2024 $0 $1,181 $395–$3,326 $164
2025 $103 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic Vascular, Inc. $353,301 159 payments
  2. Abbott Laboratories $10,834 20 payments
  3. Edwards Lifesciences Corporation $7,858 4 payments
  4. Boston Scientific Corporation $1,468 4 payments
  5. JenaValve Technology, Inc. $241 1 payment
  6. Medtronic, Inc. $103 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $228,803 38 payments
  2. Travel and Lodging $127,495 84 payments
  3. Consulting Fee $13,005 4 payments
  4. Food and Beverage $4,502 63 payments
Products named General payments · program years 2019–2025
  1. CoreValve Evolut $345,965 156 payments
  2. Trifecta Tissue Heart Valve $8,954 3 payments
  3. Edwards SAPIEN 3 Transcatheter Heart Valve $7,750 3 payments
  4. Mitra Clip system $1,759 15 payments
  5. WATCHMAN $1,468 4 payments
  6. JenaValve Pericardial TAVR System $241 1 payment
  7. Trifecta GT Tissue Heart Valve $113 1 payment
  8. 3F $23 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

189 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record